Opinion|Videos|February 14, 2025

Final Thoughts on Bispecifics in B-Cell Lymphomas From ASH 2024

Panelists share their final thoughts on bispecific therapies in B-cell lymphomas based on insights from the 66th American Society of Hematology (ASH) Annual Meeting and Exposition 2024.

Video content above is prompted by the following:

Thanks to all of you for this rich and informative discussion. Before we conclude, I’d like to get final thoughts from each of you.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.


Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo